BRPI0412189A - composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2 - Google Patents

composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2

Info

Publication number
BRPI0412189A
BRPI0412189A BRPI0412189-9A BRPI0412189A BRPI0412189A BR PI0412189 A BRPI0412189 A BR PI0412189A BR PI0412189 A BRPI0412189 A BR PI0412189A BR PI0412189 A BRPI0412189 A BR PI0412189A
Authority
BR
Brazil
Prior art keywords
composition
diabetes mellitus
dysfunction
treating
preventing type
Prior art date
Application number
BRPI0412189-9A
Other languages
English (en)
Inventor
Clara Lucia Garcia-Rodenas
Martial Dangin
Paolo Tessari
John Bruce German
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=33547601&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BRPI0412189(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BRPI0412189A publication Critical patent/BRPI0412189A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20—Milk; Whey; Colostrum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Virology (AREA)
  • Cell Biology (AREA)
  • Emergency Medicine (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Developmental Biology & Embryology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)

Abstract

"COMPOSIçãO PARA TRATAR E/OU PREVENIR DISFUNçõES ASSOCIADAS à DIABETES MELITO DO TIPO 2". A presente invenção refere-se ao uso de uma composição para tratar, prevenir e/ou melhorar disfunções metabólicas associadas à diabetes melito do Tipo 2 e resistência à insulina, a dita composição compreendendo proteína de soro intacta, e às composições nutricionais ou farmacêuticas e produtos alimentícios funcionais.
BRPI0412189-9A 2003-06-30 2004-06-30 composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2 BRPI0412189A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03014816 2003-06-30
PCT/EP2004/007094 WO2005000325A2 (en) 2003-06-30 2004-06-30 Composition for treating and/or preventing dysfunctions associated with type 2 diabetes mellitus

Publications (1)

Publication Number Publication Date
BRPI0412189A true BRPI0412189A (pt) 2006-08-22

Family

ID=33547601

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0412189-9A BRPI0412189A (pt) 2003-06-30 2004-06-30 composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2
BRPI0412182-1A BRPI0412182A (pt) 2003-06-30 2004-06-30 composição para tratamento e/ou prevenção de disfunções associadas com diabetes melito do tipo 2 e resistência à insulina

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0412182-1A BRPI0412182A (pt) 2003-06-30 2004-06-30 composição para tratamento e/ou prevenção de disfunções associadas com diabetes melito do tipo 2 e resistência à insulina

Country Status (13)

Country Link
US (2) US20060159770A1 (pt)
EP (2) EP1648483B1 (pt)
JP (1) JP2009513505A (pt)
CN (2) CN1835762B (pt)
AT (1) ATE397453T1 (pt)
BR (2) BRPI0412189A (pt)
CA (2) CA2531058A1 (pt)
DE (1) DE602004014275D1 (pt)
ES (1) ES2307020T3 (pt)
IL (2) IL172898A0 (pt)
PT (1) PT1648483E (pt)
WO (4) WO2005002602A2 (pt)
ZA (2) ZA200600812B (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2005538704A (ja) * 2002-07-01 2005-12-22 ユニリーバー・ナームローゼ・ベンノートシヤープ 満腹誘導組成物
EP1571925A1 (en) * 2002-12-20 2005-09-14 Unilever N.V. Blood glucose regulating composition
DE10331202A1 (de) 2003-07-10 2005-03-31 S.K. Enterprise Gmbh Verwendung von Molkenpermeat zur Behandlung des Metabolischen Syndroms
EP1774973A1 (en) * 2005-10-12 2007-04-18 Nutricia N.V. Leucine rich composition
DE102006036285A1 (de) 2006-08-03 2008-02-07 "S.U.K." Beteiligungs Gmbh Fraktionen aus Molkepermeat und deren Verwendung zur Prävention und Therapie des Typ-2 Diabetes und des Metabolischen Syndroms
US20080107787A1 (en) * 2006-11-02 2008-05-08 The Coca-Cola Company Anti-Diabetic Composition with High-Potency Sweetener
CA2676518A1 (en) 2008-08-29 2010-02-28 Kraft Foods Global Brands Llc Whey protein pre-load
JP2010105946A (ja) * 2008-10-29 2010-05-13 Nof Corp 筋タンパク質増強剤及びこれを含む医薬品または食品
EP2583562A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
EP2583564A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for improving insulin profile in diabetic patients
AU2013204801B2 (en) 2012-05-23 2014-11-06 Omniblend Innovation Pty Ltd Composition and method for management of diabetes or pre-diabetes
MX2015003660A (es) * 2012-09-21 2015-06-05 Abbott Lab Composiciones nutricionales que incluyen beta-hidroxi-beta-metilbu tirato de calcio, proteina y bajos niveles de electrolitos.
WO2014134225A2 (en) * 2013-02-26 2014-09-04 Pronutria, Inc. Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance
JP2016000707A (ja) * 2014-06-12 2016-01-07 有限会社 坂本薬草園 インスリン抵抗性改善剤

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU698980A1 (ru) * 1977-11-03 1979-11-25 Ордена Ленина Институт Элементоорганических Соединений Ан Ссср Способ получени смеси аминокислот
US4496606A (en) * 1983-04-29 1985-01-29 Nabisco Brands, Inc. Guar gum food bar
US4921877A (en) * 1986-10-27 1990-05-01 Abbott Laboratories Liquid nutritional formula for glucose intolerance
JPH0327262A (ja) * 1989-06-22 1991-02-05 Sanpuku Seimen:Kk りんごファイバー入り麺類
CN1087495A (zh) * 1993-11-16 1994-06-08 朱建华 低热量保健饮料及其制作方法
CN1146305A (zh) * 1995-09-28 1997-04-02 石河子医学院 糖尿病营养粉
US5795606A (en) * 1995-10-02 1998-08-18 Hercules Incorporated Method for preparing a coated food
RU2087531C1 (ru) * 1996-05-28 1997-08-20 Владимир Константинович Латов Способ получения пищевого биологически-активного продукта переработки дрожжей
US20030113390A1 (en) * 1998-11-25 2003-06-19 Hoie Lars Henrik Composition comprising soy protein, dietary fibers and a phytoestrogen compound and use thereof in the prevention and/or treatment of various diseases
US6462029B1 (en) * 1999-02-23 2002-10-08 Econugenics Compositions and methods for treating mammals with modified alginates and modified pectins
GB9927603D0 (en) * 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
WO2001056959A1 (en) * 2000-02-01 2001-08-09 Stevia Aps A substance for the use in a dietary supplementation or for the preparation of a medicament for the treatment of non-insulin dependent diabetes mellitus, hypertension and/or the metabolic syndrome
US6207638B1 (en) * 2000-02-23 2001-03-27 Pacifichealth Laboratories, Inc. Nutritional intervention composition for enhancing and extending satiety
JP3633852B2 (ja) * 2000-06-06 2005-03-30 伶輝 程 三価クロム複合物、その乳製品およびその製造方法
US6365176B1 (en) * 2000-08-08 2002-04-02 Functional Foods, Inc. Nutritional supplement for patients with type 2 diabetes mellitus for lipodystrophy
DE20017622U1 (de) * 2000-10-13 2001-04-12 Neuendorf, Ernst-Günter, 31737 Rinteln Mischpressling als Vollwert-Alleinfutter
EP1383523B1 (de) * 2001-03-02 2006-06-07 Lichtwer Pharma AG Kombinationspräparat zur behandlung des diabetes mellitus
DE10117185A1 (de) * 2001-03-02 2002-10-02 Trepel Friedrich Mittel zur Behandlung des Diabetes mellitus
DE60234780D1 (de) * 2001-08-31 2010-01-28 Univ Rutgers Verfahren zur behandlung von krankheiten mit pflanzenextrakten
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
US6706305B2 (en) * 2001-10-31 2004-03-16 Conagra Foods Inc. Low glycemic index bread
DE60301677T2 (de) * 2002-02-04 2006-07-06 Kyowa Hakko Kogyo Co., Ltd. Pharmazeutische und Lebenmittelzusammensetzungen mit einem Di- oder Oligosaccharid, das die Insulinfreisetzung steigert

Also Published As

Publication number Publication date
JP2009513505A (ja) 2009-04-02
CA2531058A1 (en) 2005-01-06
WO2005002600A3 (en) 2005-03-31
CN1835760A (zh) 2006-09-20
PT1648483E (pt) 2008-06-23
ES2307020T3 (es) 2008-11-16
DE602004014275D1 (de) 2008-07-17
EP1653980A2 (en) 2006-05-10
WO2005002602A3 (en) 2005-04-14
IL172916A0 (en) 2006-06-11
EP1648483A1 (en) 2006-04-26
EP1648483B1 (en) 2008-06-04
WO2005002600A2 (en) 2005-01-13
US20060159770A1 (en) 2006-07-20
US20060148754A1 (en) 2006-07-06
ZA200600818B (en) 2007-04-25
WO2005002612A1 (en) 2005-01-13
WO2005000325A2 (en) 2005-01-06
WO2005000325A3 (en) 2005-04-14
CA2531081A1 (en) 2005-01-13
CN1835762A (zh) 2006-09-20
ZA200600812B (en) 2007-04-25
BRPI0412182A (pt) 2006-08-22
CN1835762B (zh) 2010-05-12
WO2005002602A2 (en) 2005-01-13
IL172898A0 (en) 2006-06-11
WO2005002612A8 (en) 2006-04-06
ATE397453T1 (de) 2008-06-15

Similar Documents

Publication Publication Date Title
BRPI0412189A (pt) composição para tratar e/ou prevenir disfunções associadas à diabetes melito do tipo 2
MXPA05009933A (es) Composiciones que comprenden acidos grasos y aminoacidos.
BRPI0511703A (pt) composto, composição farmacêutica, e, métodos de tratar diabete melito tipo 2, de retardar o inìcio do diabete melito tipo 2, de tratar hiperglicemia, diabete ou resistência à insulina, obesidade, sìndrome x, um distúrbio lipìdico, aterosclerose, e uma condição
BRPI0411484A (pt) composto, formulação farmacêutica, métodos de tratamento ou prevenção de distúrbios de lipìdeo (dislipidemia), e de diabetes do tipo 2, uso de um composto, e, composição farmacêutica
CL2007001006A1 (es) Compuestos derivados de piperidina u 8-aza-biciclo[3.2.1]octano sustituidos; formulacion farmaceutica; producto; y uso para el tratamiento o prevencion de enfermedades tales como diabetes mellitus no insulino dependiente, artritis, obesidad, dislipid
WO2007004878A3 (en) Infant nutrition with hydrolised proteins
EA202190477A1 (ru) Ацилированные миметики кальцитонина
BRPI0718596B8 (pt) composições farmacêuticas para terapia de combinação com inibidores de sglt-2 e metformina
CL2006003672A1 (es) Compuestos derivados de pirimido-[4,5-b]-oxazinas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes mellitus y/u obesidad.
JP2004182630A5 (pt)
TW200628149A (en) Nutritional composition for improving skin condition and preventing skin diseases
EP4397370A3 (en) Composition comprising lactobacillus bacterium-derived vesicle for preventing or treating obesity or insulin resistance
CY1108138T1 (el) Χρησιμοποιηση λουπινοκονγλουτινης δια την θεραπευτικη αγωγη διαβητου τυπου ιι
MX2008004734A (es) Composicion rica en leucina.
AU2014386720A1 (en) Uric acid-lowering agent
WO2007044591A3 (en) Vasoactive intestinal polypeptide pharmaceuticals
NO20054798L (no) Prosessert fettpreparat for forebygging/bedring av livsstils-relaterte sykdommer
EP2050442A4 (en) PHARMACEUTICAL COMPOSITION FOR THE PREVENTION AND / OR TREATMENT OF BONE DISORDERS, FUNCTIONAL FOOD OR HEALTH MEASURES CONTAINING THIS COMPOSITION AND PHARMACEUTICAL PREPARATION CONTAINING THE COMPOSITION AS AN ACTIVE SUBSTANCE
ATE361065T1 (de) Pharmazeutische zusammensetzung zur kontrolle des blutzuckers bei patienten mit typ 2 diabetes
BRPI0413481A (pt) cascas de lêvedos para o tratamento ou a prevenção da hiperglicemia ou para a estabilização da glicemia
PL2193789T3 (pl) Zastosowanie 5-metylo-1,3-benzenodiolu lub jego pochodnych w przygotowaniu leku i funkcjonalnej żywności do leczenia lub zapobiegania depresji
EP2096120A3 (en) Use of secreted protein products for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome
WO2005092362A3 (de) Pharmazeutisches kombinationspräparat enthaltend ein therapeutisches protein
ATE541616T1 (de) Functional-food-zusammensetzungen enthaltend epigallocatechin und himbeerketon
Meduri et al. Methylprednisolone infusion in patients with early acute respiratory distress syndrome (ARDS) significantly improves lung function: results of a randomized controlled trial (RCT)

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2159 DE 22/05/2012.